Trypan Blue Versus Brillant Blue for Epiretinal Membranes
NCT ID: NCT00757380
Last Updated: 2016-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2008-07-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brillant Blue Versus Indocyanine Green for Macular Hole Surgery
NCT00757471
Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
NCT03457584
New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes
NCT06948851
UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue
NCT00437593
Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes
NCT06459284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Trypan Blue
Trypan Blue
Membranepeeling with TB
Group 2
Brillant Blue
Brillant Blue
Membranepeeling and membrana limitans interna peeling with BB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trypan Blue
Membranepeeling with TB
Brillant Blue
Membranepeeling and membrana limitans interna peeling with BB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Phakic or pseudophakic eyes
* Age over 60 years
Exclusion Criteria
* Severe ocular pathologies
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Christiane I. Falkner-Radler
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katharina Kreppler, Univ. Doz. Dr.
Role: STUDY_CHAIR
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Christiane I Falkner-Radler, Dr.
Role: PRINCIPAL_INVESTIGATOR
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FR-4-CI-2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.